Pharmaceutical Approval Update.

Pharmaceutical Approval Update. P T. 2019 Jan;44(2):42-44 Authors: Kaufman MB Abstract Arikayce (amikacin liposome inhalation suspension) for Mycobacterium avium complex lung disease; Xofluza (baloxavir marboxil) for acute uncomplicated influenza; and Nuzyra (omadacycline) for community-acquired bacterial pneumonia and/or acute bacterial skin and skin structure infections. PMID: 30766008 [PubMed]
Source: P and T - Category: Drugs & Pharmacology Tags: P T Source Type: research